Literature DB >> 33972370

Risky Business: Oropharyngeal Bacteria Linked to Risk for Invasive Fungal Infection.

Anna Dongari-Bagtzoglou1.   

Abstract

This work combines a clinical investigation with a mouse model of fungal infection to study the role of bacterial microbiota in fungal invasion. The investigators identified a dysbiosis in the oropharyngeal mucosa that was associated with a high risk for invasive infection in hematologic oncology patients. This study builds on our current understanding that the pathogenesis of fungal infections has to be studied in the context of a specific host background and a site-specific bacterial microbiota.

Entities:  

Keywords:  dysbiosis

Mesh:

Year:  2021        PMID: 33972370      PMCID: PMC8281084          DOI: 10.1128/IAI.00174-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

Review 1.  Murine models of Candida gastrointestinal colonization and dissemination.

Authors:  Andrew Y Koh
Journal:  Eukaryot Cell       Date:  2013-09-13

Review 2.  The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside.

Authors:  G T Cole; A A Halawa; E J Anaissie
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

3.  Bacterial flora accompanying Candida yeasts in clinical specimens.

Authors:  C Hermann; J Hermann; U Munzel; R Rüchel
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

4.  Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.

Authors:  Brian M Peters; Mairi C Noverr
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

5.  Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.

Authors:  Eric F Kong; Sona Kucharíková; Patrick Van Dijck; Brian M Peters; Mark E Shirtliff; Mary Ann Jabra-Rizk
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

Review 6.  Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations.

Authors:  Livio Pagano; Alessandro Busca; Anna Candoni; Chiara Cattaneo; Simone Cesaro; Rosa Fanci; Gianpaolo Nadali; Leonardo Potenza; Domenico Russo; Mario Tumbarello; Annamaria Nosari; Franco Aversa
Journal:  Blood Rev       Date:  2016-09-17       Impact factor: 8.250

7.  Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism?

Authors:  Danielle A Garsin; Michael C Lorenz
Journal:  Gut Microbes       Date:  2013-08-14

8.  Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.

Authors:  Bo-Young Hong; Takanori Sobue; Linda Choquette; Amanda K Dupuy; Angela Thompson; Joseph A Burleson; Andrew L Salner; Peter K Schauer; Pujan Joshi; Evan Fox; Dong-Guk Shin; George M Weinstock; Linda D Strausbaugh; Anna Dongari-Bagtzoglou; Douglas E Peterson; Patricia I Diaz
Journal:  Microbiome       Date:  2019-04-25       Impact factor: 14.650

9.  Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection.

Authors:  Martinna Bertolini; Amit Ranjan; Angela Thompson; Patricia I Diaz; Takanori Sobue; Kendra Maas; Anna Dongari-Bagtzoglou
Journal:  PLoS Pathog       Date:  2019-04-22       Impact factor: 7.464

10.  High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis.

Authors:  Ying Taur; Tobias M Hohl; Bing Zhai; Mihaela Ola; Thierry Rolling; Nicholas L Tosini; Sari Joshowitz; Eric R Littmann; Luigi A Amoretti; Emily Fontana; Roberta J Wright; Edwin Miranda; Charlotte A Veelken; Sejal M Morjaria; Jonathan U Peled; Marcel R M van den Brink; N Esther Babady; Geraldine Butler
Journal:  Nat Med       Date:  2020-01-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.